CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Cinacalcet hydrochloride

Last Updated: August 20, 2004
Result type: Reports
Project Number: S0018
Product Line: Reimbursement Review

Generic Name: Cinacalcet hydrochloride

Brand Name: Sensipar

Manufacturer: Amgen Canada Inc.

Indications: Secondary hyper-parathyroidism in chronic kidney disease

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 23, 2005

Recommendation Type: Do not list